ArticleBMC geriatrics2026
Geriatric and cardiometabolic syndromes in older adults with sarcopenic obesity: a comparative cross-sectional study with sarcopenia and obesity.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSarcopenic obesity (SO) is defined as the coexistence of sarcopenia (loss of muscle mass and strength) and obesity. Sarcopenic obesity (SO) is defined as the coexistence of sarcopenia, characterized by loss of muscle mass and strength, and obesity. It represents a growing but underrecognized condition among older adults, particularly in low- and middle-income countries.
aimTo determine the prevalence of sarcopenic obesity and examine its association with cardiometabolic comorbidities, geriatric syndromes, and metabolic biomarkers among hospital-attending older adults in India.
resultsAmong the total participants screened (n = 419), we found that the prevalence of SO was 7.15%. SO patients had a significantly higher burden of comorbidities, including hypertension (67.74%), diabetes mellitus (70.97%), and hypothyroidism (35.48%) compared to other groups and individuals with SO were 6.4 times more likely to have cardiovascular comorbidity in comparison to the control group. While among the geriatric syndromes, the risk of malnutrition (51.6%) was more frequent. Additionally, among the blood biomarkers, elevated HbA1c (7.52 ± 1.43%) was significant in the SO group, indicating increased metabolic dysregulation risks.
conclusionsSarcopenic obesity is prevalent among hospital-seeking older individuals in India and is associated with significant comorbidities, malnutrition, (CRP, total cholesterol, triglycerides, and HbA1c), underscoring increased inflammatory and metabolic risks in this population. There is a need to conduct prospective studies with larger samples to confirm the association and identify risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.